The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kicherova O.A.

Tyumen State Medical University

Reikhert L.I.

Tyumen State Medical University

Ahmet’yanov M.A.

Tyumen State Medical University

Deeva M.V.

Tyumen State Medical University

Makarova D.V.

Tyumen State Medical University

Cognitive consequences of COVID-19

Authors:

Kicherova O.A., Reikhert L.I., Ahmet’yanov M.A., Deeva M.V., Makarova D.V.

More about the authors

Read: 2556 times


To cite this article:

Kicherova OA, Reikhert LI, Ahmet’yanov MA, Deeva MV, Makarova DV. Cognitive consequences of COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(11):7‑10. (In Russ.)
https://doi.org/10.17116/jnevro20221221117

Recommended articles:
Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):81-90
The role of drug Cyto­flavin in the correction of dysautonomia in patients with post-COVID syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):140-146
Cognitive impairment in bili­nguals with neurological diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):26-29
Differentiated approach to cognitive reha­bilitation of patients after stroke. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6):5-11

References:

  1. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurology. 2020;77(6):683-690.  https://doi.org/10.1001/jamaneurol.2020.1127
  2. Hamming I, Timens W, Bulthuis ML, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203:631-637.  https://doi.org/10.1002/path.1570
  3. Daly JL, Simonetti B, Klein K, et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science. 2020;370:861-865.  https://doi.org/10.1126/science.abd3072
  4. Qi J, Zhou Y, Hua J, et al. The scRNA-seq expression profiling of the receptor ACE2 and the cellular protease TMPRSS2 reveals human organs susceptible to COVID-19 infection. BioRxiv. 2020(2020), 2004.2016.045690. https://doi.org/10.3390/ijerph18010284
  5. Matschke J, Lütgehetmann M, Hagel C, et al. Neuropathology of patients with covid-19 in germany: a post-mortem case series. Lancet Neurol. 2020;19(11):919-929.  https://doi.org/10.1016/S1474-4422(20)30308-2
  6. Ehrengruber MU, Ehler E, Billeter MA, Naim HY. Measles virus spreads in rat hippocampal neurons by cell-to-cell contact and in a polarized fashion. J Virol. 2002;76:5720-5728. https://doi.org/10.1128/jvi.76.11.5720-5728.2002
  7. Brann DH, Tsukahara T, Weinreb C, et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv. 2020;6:eabc5801. https://doi.org/10.1126/sciadv.abc5801
  8. Chen R, Yu J, Wang K, et al. The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in human and mouse brain. BioRxiv. 2020(2020), 2004.2007.030650. https://doi.org/10.3389/fneur.2020.573095
  9. Xia S, Liu M, Wang C, et al. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res. 2020;30:343-355.  https://doi.org/10.1038/s41422-020-0305-x
  10. Puelles VG, Lütgehetmann M, Lindenmeyer MT, et al. Multiorgan and renal tropism of sars-cov-2. N Engl J Med. 2020;383(6):590-592.  https://doi.org/10.1056/NEJMc2011400
  11. Dubé M, Le Coupanec A, Wong AHM, et al. Axonal transport enables neuron-to-neuron propagation of human coronavirus oc43. J Virol. 2018;92:e00404-e418. https://doi.org/10.1128/JVI.00404-18
  12. Jin Y, Ji W, Yang H, et al. Endothelial activation and dysfunction in COVID-19: From basic mechanisms to potential therapeutic approaches. Signal Transduct. Target Ther. 2020;5:293.  https://doi.org/10.1038/s41392-020-00454-7
  13. Stefano GB, Ptacek R, Ptackova H, et al. Selective Neuronal Mitochondrial Targeting in SARS-CoV-2 Infection Affects Cognitive Processes to Induce ‘Brain Fog’ and Results in Behavioral Changes that Favor Viral Survival. Med Sci Monit. 2021;27:e930886. https://doi.org/10.12659/MSM.930886
  14. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.  https://doi.org/10.1016/S0140-6736(20)30183-5
  15. The Great British intelligence test. https://www.bbc.co.uk/programmes/articles/5tFHwWMgg9VbrHT9kvGlFqd/the-great-british-intelligence-test
  16. Hampshirea A, Trendera W, Chamberlainb SR, et al. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021;39:101044. https://doi.org/10.1016/j.eclinm.2021.101044
  17. Tabacof L, Tosto-Mancuso J, Wood J, et al. Post-acute COVID-19 Syndrome Negatively Impacts Physical Function, Cognitive Function, Health-Related Quality of Life, and Participation. Am J Phys Med Rehabil. 2022;101(1):48-52.  https://doi.org/10.1097/PHM.0000000000001910
  18. Lamontagne SJ, Winters MF, Pizzagalli DA, Olmstead MC. Post-acute sequelae of COVID-19: Evidence of mood & cognitive impairment. Brain Behav Immun Health. 2021;17:100347. https://doi.org/10.1016/j.bbih.2021.100347
  19. Evans RA, McAuley H, Harrison EM, et al. Brightling, on behalf of the PHOSP-COVID Collaborative Group. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med. 2021;9(11):1275-1287. https://doi.org/10.1016/S2213-2600(21)00383-0
  20. Liu Y-H, Wang Y-R, Wang Q-H, et al. Post-infection cognitive impairments in a cohort of elderly patients with COVID-19. Mol Neurodegener. 2021;16(1):48.  https://doi.org/10.1186/s13024-021-00469-w
  21. Ferrucci R, Dini M, Rosci C, et al. One-year cognitive follow-up of COVID-19 hospitalized patients. Eur J Neurol. 2022;29(7):2006-2014. https://doi.org/10.1111/ene.15324
  22. Cristillo V, Pilotto A, Piccinelli SC, et al. Neuro Covid Next Study group. Premorbid vulnerability and disease severity impact on Long-COVID cognitive impairment. Aging Clin Exp Res. 2022;34(1):257-260.  https://doi.org/10.1007/s40520-021-02042-3
  23. Duca A, Pivo S, Focà E, et al. Calculated Decisions: Brescia-COVID Respiratory Severity Scale (BCRSS). Algorithm. Emerg Med Pract. 2020;22 (5 suppl):CD1-CD2. 
  24. Hollocks MJ, Brookes RL, Morris RG, Markus HS. The Brief Memory and Executive Test (BMET): A cognitive screening tool to detect and differentiate vascular cognitive impairment and Alzheimer’s disease. Int J Geriatr Psychiatry. 2018;33(2):273-279.  https://doi.org/10.1002/gps.4787
  25. Cecchetti G, Agosta F, Canu E, et al. Cognitive, EEG, and MRI features of COVID 19 survivors: a 10 month Study. J Neurol. 2022;34(8):1-13.  https://doi.org/10.1007/s00415-022-11047-5
  26. Crivelli L, Calandri I, Corvalan N, et al. Cognitive consequences of COVID-19: results of a cohort study from South America. Arq Neuropsiquiatr. 2022;80(3):240-247.  https://doi.org/10.1590/0004-282X-ANP-2021-0320
  27. Jaywant A, Vanderlind WM, Alexopoulos GS, et al. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology. 2021;46(13):2235-2240. https://doi.org/10.1038/s41386-021-00978-8
  28. Alemanno F, Houdayer E, Parma A, et al. COVID-19 cognitive deficits after respiratoryassistance in the subacute phase: A COVID rehabilitation unit experience. PLoS One. 2021;16(2):e0246590. https://doi.org/10.1371/journal.pone.0246590
  29. Miskowiak KW, Johnsen S, Sattler SM, et al. Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables. Eur Neuropsychopharmacol. 2021;46:39-48.  https://doi.org/10.1016/j.euroneuro.2021.03.019
  30. Chen C, Haupert SR, Zimmermann L, et al. Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review. J Infect Dis. 2022;jiac136. https://doi.org/10.1093/infdis/jiac136
  31. Ceban F, Ling S, Lui LMW, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun. 2022;101:93-135.  https://doi.org/10.1016/j.bbi.2021.12.020
  32. Badenoch JB, Rengasamy ER, Watson C, et al. Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis. Brain Commun. 2021;4(1):fcab297. https://doi.org/10.1093/braincomms/fcab297
  33. Mattioli F, Stampatori C, Righetti F, et al. Neurological and cognitive sequelae of Covid 19: a four month follow up. J Neurol. 2021;268(12):4422-4428. https://doi.org/10.1007/s00415-021-10579-6
  34. Del Brutto OH, Rumbea DA, Recalde BY, Mera RM. Cognitive sequelae of long COVID may not be permanent: Aprospective study. Eur J Neurol. 2022;29(4):1218-1221. https://doi.org/10.1111/ene.15215

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.